LANTHEUS HOLDINGS INC
LANTHEUS HOLDINGS INC
Acción · US5165441032 · LNTH · A117UE (XNMS)
Resumen Indicadores financieros
72,20 USD
-0,29 % -0,21 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Precios actuales y gráficos en MoneyPeak
29.07.2025 20:00

Cotizaciones actuales de LANTHEUS HOLDINGS INC

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
LNTH
USD
29.07.2025 20:00
72,20 USD
-0,21 USD
-0,29 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % -1,51 % -11,40 % -30,55 % -21,97 % -35,30 % 359,58 %

Perfil de la empresa para LANTHEUS HOLDINGS INC Acción

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.

Datos de la empresa

Nombre LANTHEUS HOLDINGS INC
Empresa Lantheus Holdings, Inc.
Símbolo LNTH
Sitio web https://www.lantheus.com
Mercado principal XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A117UE
ISIN US5165441032
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - Specialty & Generic
CEO Mr. Brian A. Markison
Capitalización de mercado 6 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,8 T
Dirección 331 Treble Cove Road, 01862 Bedford
Fecha de OPV 2015-06-25

Símbolos de cotización

Nombre Símbolo
Frankfurt 0L8.F
NASDAQ LNTH

Otras acciones

Los inversores que tienen LANTHEUS HOLDINGS INC también tienen las siguientes acciones en su cartera:
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Acción
AMGEN INC
AMGEN INC Acción
APPLIED MATERIALS INC
APPLIED MATERIALS INC Acción
AUTODESK INC
AUTODESK INC Acción
CDW CORP
CDW CORP Acción
CISCO SYSTEMS INC
CISCO SYSTEMS INC Acción
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Acción
INTEL CORP
INTEL CORP Acción
JYSKE BANK 25/31 FLR MTN
JYSKE BANK 25/31 FLR MTN Bono
SG ISSUER NTS 12/10/21
SG ISSUER NTS 12/10/21 Bono
SHERRITT INTL CORP
SHERRITT INTL CORP Acción
SKYWORKS SOLUTIONS INC
SKYWORKS SOLUTIONS INC Acción
SYNOPSYS INC
SYNOPSYS INC Acción
TRI STYLE FUND VT
TRI STYLE FUND VT Fondo
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025